Enhancement of LAK-like activity and cytokine induction in regional lymph nodes and spleen cells of mice after intralymphnodal injection of OK-432, a killed streptococcal preparation
| Autor: | Sadayuki Sasaki, Toshio Takahashi, Akeo Hagiwara, K Ozaki, Seiji Sawai, Tetsuro Yamane, Chouhei Sakakura, Hiroyuki Tsujimoto, Shinji Okano |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
Cytotoxicity
Immunologic Male Cancer Research Time Factors medicine.drug_class medicine.medical_treatment Mice Inbred Strains chemical and pharmacologic phenomena Spleen Monoclonal antibody Sensitivity and Specificity Picibanil Mice medicine Animals Pharmacology (medical) Killer Cells Lymphokine-Activated Lymph node Pharmacology biology Chemistry Antibodies Monoclonal Injections Intralymphatic Interleukin Complement System Proteins Neoplasms Experimental Killer Cells Natural Cytokine medicine.anatomical_structure Oncology Immunology biology.protein Cancer research Cytokines Tumor necrosis factor alpha Lymph Nodes Lymph Antibody |
| Zdroj: | Anti-Cancer Drugs. 4:381-388 |
| ISSN: | 0959-4973 |
| Popis: | A single dose of inactivated streptococci (OK-432) was injected into the popliteal lymph nodes of male CDF1 mice and its effects on popliteal, inguinal, and para-aortic lymph node cells and spleen cells were investigated and compared with the effects of subcutaneous injections of the same dosage of OK-432. Regional lymph node cells and spleen cells obtained from intralymphnodally injected mice lysed not only natural killer (NK)-sensitive YAC-1 cells, but also NK-resistant P-815 and meth-A cells. Lysis of target cells was inhibited when effector cells were treated with anti-Thy-1.2 or anti-Lyt-2.2 monoclonal antibody and complement, but no inhibition was apparent after treatment with anti-asialo-GM1 or anti-Lyt-1.2 antibody and complement. These results suggest that the effector cells are lymphocyte-activated killer (LAK) cells. An enhanced capacity of lymph node cells to produce cytokines, tumor necrosis factor and interleukin 1 upon restimulation with lipopolysaccharide was found only in intralymphnodally injected mice. Thus, the induction of LAK-like cells and cytokine production in regional lymph nodes and spleen cells by the intralymphnodal administration of OK-432 should be effective for the inhibition or treatment of lymph node metastases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|